Articles
Cases
News
Issues
CME / CE
Podcasts
Blog
Student Scan
Resources
SUBSCRIBE
MOST RECENT
FDA Approves New PYLARIFY TruVu Formulation for Enhanced Prostate Cancer Imaging
Telix Submits Revised New Drug Application for Brain Cancer Imaging Agent TLX101-Px to FDA
AI-Enhanced Mammography Improves Risk Prediction in Breast Cancer Screening
AidaBreast™ Validates as Predictive Tool for Breast Cancer Radiotherapy Decisions
Study Finds No Increase in Toxicity with Combined Radiation Treatments for Liver Cancer
Key Milestones Achieved in ProstACT Global Phase 3 Study of TLX591-Tx
Innovative Radiotheranostic Therapy Under Investigation for Aggressive Bone Cancer
Supplemental MRI May Benefit Women With Dense Breasts at Higher Cancer Risk
Stereotactic Radiation Therapy Outperforms Whole-Brain Radiation for Brain Metastases
2026 National Proton Conference to Highlight Key Advances and Access Initiatives